CYIOS - Road Map

Road Map

ROAD MAP

CYIOS Corp 2025 Business Roadmap

Key highlights and targets for CYIO in 2025

CYIOS has demonstrated a strong track record of growth, driven by the performance of its Noir acquisition, which generated $14.4 million in revenue in 2024 - more than triple the $4.55 million recorded in 2023.

Driving Innovation, Sustainability, and Shareholder Value in the Medical Supplies Industry

Completion of 2-year PCAOB audits and uplisting.

Increase working capital via strategic investments

CYIOS Corp to host a strategic investment presentation in the USA to showcase its 2025 business roadmap, attract potential investors, and solidify partnerships to support its growth trajectory.

Increase advisory board members.

Key members of management to be working from one location in the USA.

CYIO to increase shareholder engagement and strive to build long term shareholder value.

Pioneering technologies to streamline the medical supply chain with AI development.

Aiming for long-term growth and profitability.